https://european-biotechnology.net/wp-content/uploads/2025/05/money-bag-1189868_1280.jpg540960Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-05-07 09:02:382025-05-07 09:02:38Lilly pays US$415m for rights to ATLX-1282
https://european-biotechnology.net/wp-content/uploads/2025/05/Dynamic42_Tumor_on_Chip_sm-768x512-1.jpg512768Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-05-06 16:15:452025-05-06 16:15:45Dynamic42 GmbH starts distribution of organ-on-chip to the US and Canada
https://european-biotechnology.net/wp-content/uploads/2025/04/fab8ad76-cf6e-4e34-a523-324dc0865c50-e1745917221177-1030x579-1.webp5791030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-04-29 09:18:592025-04-29 09:18:59Yeast on the Final Frontier